Q1 Scientific

Executive Summary

Q1 Scientific, a fully owned subsidiary of Cambrex, is a leading provider of compliant stability storage and Good Distribution Practice (GDP) solutions for the pharmaceutical, biotechnology, and medical device industries. Founded in 2014 and headquartered in Waterford, Ireland, the company operates validated, ICH-compliant facilities across Ireland, Belgium, and the United States. Its services include temperature- and humidity-controlled storage, photostability testing, thermal cycling, and disaster recovery. With a workforce exceeding 1,000 employees, Q1 Scientific leverages Cambrex’s global network to serve a diverse client base, ensuring regulatory compliance and product integrity throughout the supply chain. The company’s focus on high-quality, secure storage positions it as a critical partner for drug developers and manufacturers. The stability storage market is poised for steady growth, driven by increasing biologics development, cold chain logistics demands, and regulatory scrutiny. Q1 Scientific benefits from its early mover advantage and established infrastructure. Near-term catalysts include capacity expansions at its US and European sites to meet rising demand, as well as potential service-line extensions into advanced therapies storage. Additionally, tighter FDA and EMA guidelines on GDP compliance could drive outsourcing to specialized providers like Q1 Scientific. As part of Cambrex, the company also gains access to cross-selling opportunities and integrated client solutions. While competitive pressures exist, Q1 Scientific’s validated facilities and reputation for reliability underpin its growth trajectory.

Upcoming Catalysts (preview)

• Q1 2027US facility capacity expansion to meet growing demand70% success
• TBDIntroduction of storage services for cell and gene therapies60% success
• Q4 2026Regulatory tailwinds from updated FDA/EU GDP guidelines80% success